Adalimumab Earns FDA Approval for Ulcerative Colitis in Children ...Middle East

News by : (Medscape) -
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( Adalimumab Earns FDA Approval for Ulcerative Colitis in Children )

Also on site :

Most Viewed News
جديد الاخبار